HUTCHMED Schedules 12 May 2026 Hybrid AGM; Shareholders to Vote on FY 2025 Accounts, Board Re-elections and 2026 Share Option Scheme

HUTCHMED (China) Limited has issued the proxy form and agenda for its 2026 Annual General Meeting (AGM).

The AGM is set for 4:00 p.m. Hong Kong time (9:00 a.m. London time) on Tuesday, 12 May 2026 at the Harbour Grand Kowloon, Hung Hom, with simultaneous electronic participation via an online platform. Should a tropical cyclone, black rainstorm or “extreme conditions” disrupt proceedings, the meeting will move to the same time and venue on Thursday, 14 May 2026.

Key resolutions to be decided by poll include: 1. Adoption of the audited financial statements, directors’ report and independent auditors’ report for the year ended 31 December 2025. 2. Re-election of nine directors: Dr Dan Eldar, Dr Weiguo Su, Mr Johnny Cheng, Ms Edith Shih, Ms Ling Yang, Dr Renu Bhatia, Dr Chaohong Hu, Professor Daniel Shao Weng Tan and Mr Tak Wai Wong. 3. Re-appointment of PricewaterhouseCoopers (Hong Kong) and PricewaterhouseCoopers Zhong Tian LLP (China) as independent auditors, with authorisation for the board to set their remuneration. 4. A special resolution granting a general mandate to issue additional shares. 5. An ordinary resolution authorising the board to repurchase shares. 6. Approval of a new 2026 Share Option Scheme.

Shareholders wishing to vote by proxy must submit completed forms—either by post to Computershare Hong Kong Investor Services Limited or by email to HKProxy@hutch-med.com—no later than 48 hours before the meeting. Each share carries one vote, and all resolutions will be decided by poll.

The company emphasises that votes cast through the online platform become irrevocable once the voting session closes, and shareholders who subsequently attend in person or online will have any prior proxy appointment automatically revoked upon voting.